The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 390 | 19,514 | SH | SOLE | 19,514 | 0 | 0 | ||
| ALCENTRA CAP CORP | COM | 01374T102 | 354 | 55,359 | SH | SOLE | 55,359 | 0 | 0 | ||
| ALPS ETF TR | ALERIAN MLP | 00162Q866 | 4,233 | 419,107 | SH | SOLE | 419,107 | 0 | 0 | ||
| AMERCO | COM | 023586100 | 962 | 2,700 | SH | SOLE | 2,700 | 0 | 0 | ||
| ARQULE INC | COM | 04269E107 | 72 | 12,959 | SH | SOLE | 12,959 | 0 | 0 | ||
| BERKSHIRE HATHAWAY INC DEL | CL B NEW | 084670702 | 1,738 | 9,312 | SH | SOLE | 9,312 | 0 | 0 | ||
| CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 105 | 33,801 | SH | SOLE | 33,801 | 0 | 0 | ||
| CM FIN INC | COM | 12574Q103 | 7,905 | 888,220 | SH | SOLE | 888,220 | 0 | 0 | ||
| FAR PT ACQUISITION CORP | UNIT 06/01/2025 | 30734W208 | 225 | 22,104 | SH | SOLE | 22,104 | 0 | 0 | ||
| GARRISON CAP INC | COM | 366554103 | 9,094 | 1,118,529 | SH | SOLE | 1,118,529 | 0 | 0 | ||
| GTX INC DEL | COM NEW | 40052B207 | 763 | 49,805 | SH | SOLE | 49,805 | 0 | 0 | ||
| INTEC PHARMA LTD JERUSALEM | SHS | M53644106 | 285 | 64,817 | SH | SOLE | 64,817 | 0 | 0 | ||
| JBG SMITH PPTYS | COM | 46590V100 | 1,501 | 41,170 | SH | SOLE | 41,170 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 299 | 16,415 | SH | SOLE | 16,415 | 0 | 0 | ||
| MARINUS PHARMACEUTICALS INC | COM | 56854Q101 | 93 | 13,105 | SH | SOLE | 13,105 | 0 | 0 | ||
| MEI PHARMA INC | COM NEW | 55279B202 | 17,338 | 4,400,439 | SH | SOLE | 4,400,439 | 0 | 0 | ||
| MOLECULAR TEMPLATES INC | COM | 608550109 | 5,511 | 1,053,787 | SH | SOLE | 1,053,787 | 0 | 0 | ||
| PG&E CORP | COM | 69331C108 | 958 | 22,500 | SH | SOLE | 22,500 | 0 | 0 | ||
| SCYNEXIS INC | COM | 811292101 | 4,846 | 2,955,000 | SH | SOLE | 2,955,000 | 0 | 0 | ||
| SIERRA ONCOLOGY INC | COM | 82640U107 | 100 | 33,731 | SH | SOLE | 33,731 | 0 | 0 | ||
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 192,636 | 710,100 | SH | Put | SOLE | 710,100 | 0 | 0 | |
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 32,388 | 5,398,034 | SH | SOLE | 5,398,034 | 0 | 0 | ||
| SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 103 | 48,707 | SH | SOLE | 48,707 | 0 | 0 | ||
| TAPIMMUNE INC | COM PAR | 876033408 | 798 | 84,674 | SH | SOLE | 84,674 | 0 | 0 | ||
| TRIANGLE CAP CORP | COM | 895848109 | 302 | 26,286 | SH | SOLE | 26,286 | 0 | 0 | ||